scholarly article | Q13442814 |
P2093 | author name string | Xiao-Jun Huang | |
Ying-Jun Chang | |||
Xiang-Yu Zhao | |||
Ming-Rui Huo | |||
P2860 | cites work | Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD | Q81014631 |
Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers | Q81676892 | ||
Short-term homing assay reveals a critical role for lymphocyte function-associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus-host disease | Q82505877 | ||
Leukocyte migration and graft-versus-host disease | Q30479618 | ||
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 | ||
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis | Q34337007 | ||
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine | Q35848654 | ||
A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease | Q36363382 | ||
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs | Q36478455 | ||
Selectins--potential pharmacological targets? | Q36630618 | ||
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells | Q36658080 | ||
Progress in acute graft versus host disease | Q36953081 | ||
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges | Q37023497 | ||
Late effects of chronic graft-versus-host disease | Q37173489 | ||
Chronic graft-versus-host disease and other late complications of bone marrow transplantation. | Q37295704 | ||
The role of donor lymphoid cells in allogeneic marrow engraftment | Q38037580 | ||
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. | Q40539710 | ||
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease | Q40627364 | ||
Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells | Q44006790 | ||
LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease | Q44620762 | ||
Allogenic stem cell transplantation from genotypically HLA-identical siblings for 30 patients with myelodysplastic syndromes | Q44923755 | ||
In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. | Q45182123 | ||
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation | Q46870128 | ||
Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset. | Q47214419 | ||
Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at l-selectin and alpha4-integrin prior to infusion | Q47614127 | ||
Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect | Q47989352 | ||
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. | Q52006998 | ||
Lifespan of human lymphocyte subsets defined by CD45 isoforms | Q52069544 | ||
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. | Q53589050 | ||
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts | Q56909451 | ||
Interleukin-11 induces Th2 polarization of human CD4(+) T cells | Q57007772 | ||
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation | Q57252638 | ||
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants. | Q58416258 | ||
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host disease | Q71577663 | ||
Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease | Q73444018 | ||
Administration of G-CSF to normal individuals diminishes L-selectin+ T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin- T cells | Q77304812 | ||
Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions | Q79854792 | ||
CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin | Q79901873 | ||
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies | Q80045677 | ||
P433 | issue | 5 | |
P304 | page(s) | 696-704 | |
P577 | publication date | 2009-05-22 | |
P1433 | published in | Journal of Clinical Immunology | Q6294961 |
P1476 | title | Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation | |
P478 | volume | 29 |
Q45165373 | A direct comparison of expression profiles of adhesion molecules on naïve T cells between cord blood and steady-state bone marrow grafts of healthy donors |
Q38124285 | Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation |
Q42235412 | Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity. |
Q58093525 | Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation |
Q84255678 | High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation |
Q45365962 | High frequency of CD4+ CD25- CD69+ T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants. |
Q35155712 | Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro |
Q50860969 | Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting. |
Q57216449 | Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease |
Search more.